Open AccessStructure-based design of CDC42 effector interaction inhibitors for the treatment of cancer
Author(s) -
Sohail Jahid,
José Antonio Ortega,
Linh M. Vuong,
Isabella Maria Acquistapace,
Stephanie J. Hachey,
Jessica L. Flesher,
Maria Antonietta La Serra,
Nicoletta Brindani,
Giuseppina La Sala,
Jacopo Manigrasso,
José M. Arencibia,
Sine Mandrup Bertozzi,
Maria Summa,
Rosalia Bertorelli,
Andrea Armirotti,
Rongsheng Jin,
Zheng Liu,
ChiFen Chen,
Robert A. Edwards,
Christopher C.W. Hughes,
Marco De Vivo,
Anand K. Ganesan
Publication year - 2022
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2022.110641
Subject(s) - cdc42 , effector , angiogenesis , cancer research , gtpase , in vivo , microbiology and biotechnology , biology , cancer cell , cancer , tumor microenvironment , mapk/erk pathway , phosphorylation , tumor cells , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom